Celgene Fortifies Immuno-oncology Presence with Immatics Alliance

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 9 (Table of Contents)

Published: 3 Sep-2019

DOI: 10.3833/pdr.v2019.i9.2454     ISSN: 1756-7874

Section: Licensing



Just days after divesting its psoriasis drug Otezla® (apremilast) to Amgen in exchange for US$13...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details